(Q39021524)

8 September 2017

title

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer (English)

1 reference

8 September 2017

Xiaoti Lin

1

1 reference

8 September 2017

Minqing Wu

2

1 reference

8 September 2017

Peng Liu

3

1 reference

8 September 2017

Fengqin Wei

4

1 reference

8 September 2017

Laisheng Li

5

1 reference

8 September 2017

Hailin Tang

6

1 reference

8 September 2017

Xinhua Xie

7

1 reference

8 September 2017

Xiaoping Liu

8

1 reference

8 September 2017

Lu Yang

9

1 reference

8 September 2017

Xiaoming Xie

10

1 reference

8 September 2017

publication date

22 February 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

31

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

868

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-014-0868-9

8 September 2017

exact match

0 references

cites work

Cancer treatment and survivorship statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

The benefits and harms of breast cancer screening: an independent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Breast intervention: how I do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Breast cancer statistics, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Dissecting the heterogeneity of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

RETRACTED: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

The activity and expression of microRNAs in prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Adrenocortical carcinoma survival rates correlated to genomic copy number variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

MicroRNAs in breast cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Small non-coding RNAs govern mammary gland tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

A MicroRNA targeting dicer for metastasis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0868-9

Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors

21 January 2018

1 reference

12 December 2020

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer

1 reference

12 December 2020

Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia

1 reference

12 December 2020

Overexpression of p53 and prognosis in breast cancer

1 reference

12 December 2020

10.1007/S12032-014-0868-9

Identifiers

DOI

1 reference

8 September 2017

1 reference